DK0988040T3 - Anvendelse af glucosamin og glucasamin-derivater til hurtig lindring af klöe eller lokaliseret smerte - Google Patents

Anvendelse af glucosamin og glucasamin-derivater til hurtig lindring af klöe eller lokaliseret smerte

Info

Publication number
DK0988040T3
DK0988040T3 DK98928331T DK98928331T DK0988040T3 DK 0988040 T3 DK0988040 T3 DK 0988040T3 DK 98928331 T DK98928331 T DK 98928331T DK 98928331 T DK98928331 T DK 98928331T DK 0988040 T3 DK0988040 T3 DK 0988040T3
Authority
DK
Denmark
Prior art keywords
itching
glucosamine
derivatives
glucasamine
localized pain
Prior art date
Application number
DK98928331T
Other languages
English (en)
Inventor
Berghe Dirk Andre Richa Vanden
Original Assignee
Bio Minerals Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8228331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0988040(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Minerals Nv filed Critical Bio Minerals Nv
Application granted granted Critical
Publication of DK0988040T3 publication Critical patent/DK0988040T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK98928331T 1997-05-21 1998-05-22 Anvendelse af glucosamin og glucasamin-derivater til hurtig lindring af klöe eller lokaliseret smerte DK0988040T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97201513 1997-05-21
EP98928331A EP0988040B1 (en) 1997-05-21 1998-05-22 Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
PCT/EP1998/003175 WO1998052576A1 (en) 1997-05-21 1998-05-22 Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain

Publications (1)

Publication Number Publication Date
DK0988040T3 true DK0988040T3 (da) 2004-11-29

Family

ID=8228331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98928331T DK0988040T3 (da) 1997-05-21 1998-05-22 Anvendelse af glucosamin og glucasamin-derivater til hurtig lindring af klöe eller lokaliseret smerte

Country Status (8)

Country Link
US (1) US6495531B2 (da)
EP (1) EP0988040B1 (da)
AT (1) ATE271873T1 (da)
AU (1) AU8020698A (da)
DE (1) DE69825279T2 (da)
DK (1) DK0988040T3 (da)
ES (1) ES2221176T3 (da)
WO (1) WO1998052576A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
US6413525B1 (en) 1999-05-06 2002-07-02 Color Access, Inc. Methods of exfoliation using N-acetyl glucosamine
US20050003023A1 (en) * 2002-06-28 2005-01-06 Meisner Lorraine Faxon Topical composition for the treatment of psoriasis and related skin disorders
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
NO20013534L (no) * 2000-07-18 2002-01-21 Koyo Chemical Company Ltd Anvendelse av en blanding omfattende et glucosaminsalt eller et glucosaminderivat for fremstilling av et medikament for behandling av human trombose
US8222232B2 (en) * 2001-02-16 2012-07-17 Cargill, Incorporated Glucosamine and N-acetylglucosamine compositions and methods of making the same fungal biomass
US7923437B2 (en) * 2001-02-16 2011-04-12 Cargill, Incorporated Water soluble β-glucan, glucosamine, and N-acetylglucosamine compositions and methods for making the same
US20020182237A1 (en) * 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
CA2408023C (en) * 2002-10-15 2012-01-03 Purepharm Inc. Glucosamine as a food and beverage additive
US20070259094A1 (en) * 2002-10-21 2007-11-08 Willem Wassenaar N-acetylglucosamine as a food and beverage additive
CA2551613A1 (en) * 2004-05-21 2005-12-01 Tottori University A composition comprising n-acetyl-d-glucosamine for treatment of wound
US20070092469A1 (en) * 2005-10-26 2007-04-26 Eric Jacobs Topically applied Glucosamine Sulfate and all its related, precursor, and derivative compounds significantly increases the skin's natural produciton of hyaluronic acid for the rejuvenation of healthier younger-looking skin; while PhosphatidylCholine is required to replace its deficiency caused by topical Dimethylaminoethanol (DMAE)
US20080188649A1 (en) * 2007-02-01 2008-08-07 Hygieia Health Co., Ltd. Method for producing glucosamine from microbial biomass
WO2012154903A1 (en) 2011-05-10 2012-11-15 Active Organics, Inc. Compositions containing extracts of mucor miehei and mucor rouxii
RU2538218C2 (ru) * 2013-03-19 2015-01-10 Открытое Акционерное Общество "Татхимфармпрепараты" Лекарственное средство для лечения остеоартрозов (варианты)
AU2015419323A1 (en) * 2015-12-30 2018-07-26 Alexander Vilenovich ASAFOV Formulation for treatment of peripheral joints, spinal joints and/or extracellular matrix elements of connective tissue, method of manufacture and uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772591A (en) 1985-09-25 1988-09-20 Peritain, Ltd. Method for accelerated wound healing
EP0281812A1 (en) 1987-02-18 1988-09-14 Milor Scientific, Ltd. Composition for treatment of acne
JPH0454126A (ja) * 1990-06-21 1992-02-21 Mikio Mori 治療液及びその治療液を含有するサニタリー製品

Also Published As

Publication number Publication date
DE69825279T2 (de) 2005-08-04
WO1998052576A1 (en) 1998-11-26
DE69825279D1 (de) 2004-09-02
ES2221176T3 (es) 2004-12-16
ATE271873T1 (de) 2004-08-15
US20010053771A1 (en) 2001-12-20
EP0988040A1 (en) 2000-03-29
EP0988040B1 (en) 2004-07-28
US6495531B2 (en) 2002-12-17
AU8020698A (en) 1998-12-11

Similar Documents

Publication Publication Date Title
DK0988040T3 (da) Anvendelse af glucosamin og glucasamin-derivater til hurtig lindring af klöe eller lokaliseret smerte
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
PL336788A1 (en) Probucol monoesters in treating circulatory system and inflammatory diseases
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
PT841898E (pt) COMPOSICOES TóPICAS QUE PROPORCIONAM UMA MELHOR SENSACAO DA PELE
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
PT991619E (pt) Inibidores da adesao celular mediada pela alfa4beta1
TNSN00010A1 (fr) DIPHENYLUREE A SUBSTITUTION ω CARBOXYARYLE SERVANT D'INHIBUTEURS DE RAF KINASE.
GT199700074A (es) Derivados de 2-(2-oxo-etiliden)-imidazolidin-4-ona
TR199701669A1 (xx) Deri preparasyonu i�in bile�imler.
DK0506658T3 (da) Sammensætninger og fremgangsmåde til behandling af smertefulde, inflammatoriske eller allergiske lidelser
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
PT1144365E (pt) Inibidores da adesao de celulas mediada por alfa4beta1
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
DK0885005T3 (da) Anvendelse af dehydroepiandrosteron og aromatasehæmmere til fremstilling af et lægemiddel til behandling af en relativ og absolut androgenmangel hos mænd
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
NO970573L (no) Ylidenforbindelser og deres fremstilling
NO952601L (no) Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser
TWI262791B (en) 6-methoxy-2-naphthylacetic acid prodrugs
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
ES2159627T3 (es) Formulacion energetica.
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.